MIT Develops Implantable Device for Glioblastoma Drug Delivery

MIT researchers have created an implantable device with ultrasound transducers to improve drug delivery for aggressive brain tumors like glioblastoma. The device uses sound waves to help drugs bypass the blood-brain barrier and spread effectively, offering extended drug release and wireless programming of ultrasound dosages. This innovation could significantly enhance treatment efficacy for a challenging cancer.